Patricia G. S.
- Country
- Spain
- Department
- Servicio de Dermatologia
Research Overview
- Phase 3 Extension Study of Long-Term Safety and Efficacy of Remibrutinib in Adults With Moderate to Severe Hidradenitis Suppurativa
- Efficacy and Safety Evaluation of Ianalumab in Moderate to Severe Hidradenitis Suppurativa: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study
- Phase 3 Multicenter Randomized Double-Blind Placebo-Controlled Trial Evaluating Lutikizumab Efficacy and Safety in Moderate to Severe Hidradenitis Suppurativa
Data & Insights
Has run more than one trial at 79 of 167 partner sites.
Specializations
Inflammatory and autoimmune dermatology
Clinical research activity includes atopic dermatitis, hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and systemic lupus erythematosus, reflecting a strong therapeutic focus on chronic immune-mediated disease.
- Atopic dermatitis
- Hidradenitis suppurativa
- Psoriatic arthritis
- Systemic lupus erythematosus
Interest also extends to polymyalgia rheumatica, Behçet’s disease, Sjögren’s syndrome, and diffuse cutaneous systemic sclerosis, with emphasis on inflammatory skin and systemic autoimmune conditions.
Oncology and urothelial malignancies
Trial involvement spans breast cancer, triple-negative breast cancer, urothelial carcinoma, bladder cancer, renal cell carcinoma, and prostate cancer, indicating broad engagement in solid tumor therapeutics.
- Breast cancer
- Urothelial carcinoma
- Renal cell carcinoma
- Prostate cancer
Additional activity includes non-small cell lung cancer, colorectal cancer, melanoma, and gastroesophageal adenocarcinoma, with attention to both early-stage and advanced disease settings.
Gastroenterology and hepatology
Research interests cover primary biliary cholangitis, chronic liver disease, metabolic dysfunction-associated steatohepatitis, non-alcoholic steatohepatitis, and hepatic encephalopathy, highlighting a focus on liver-related therapeutic innovation.
- Primary biliary cholangitis
- Metabolic dysfunction-associated steatohepatitis
- Chronic liver disease
- Hepatic encephalopathy
Additional areas include Crohn’s disease, ulcerative colitis, inflammatory bowel diseases, acute pancreatitis, and gastroenteropancreatic neuroendocrine tumors.
Respiratory and infectious diseases
Clinical trial participation includes asthma, severe asthma, chronic rhinosinusitis with nasal polyps, idiopathic pulmonary fibrosis, and interstitial lung disease, showing sustained interest in airway and fibrotic lung disorders.
- Asthma
- Idiopathic pulmonary fibrosis
- Interstitial lung disease
- Chronic rhinosinusitis with nasal polyps
Infectious disease activity includes severe community-acquired pneumonia, sepsis, HIV infection, chronic hepatitis B, and Enterobacteriaceae-related infections.
Neurology, psychiatry, and metabolic disorders
Research involvement extends to major depressive disorder, schizophrenia, attention-deficit/hyperactivity disorder, migraine, and acute ischemic stroke, reflecting a therapeutic interest in neuropsychiatric and neurologic conditions.
- Major depressive disorder
- Schizophrenia
- Attention-deficit/hyperactivity disorder
- Migraine
Additional work includes Prader-Willi syndrome, Fragile X syndrome, type 2 diabetes, atherosclerotic cardiovascular disease, and venous thromboembolism.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.